The transgene contains the murine albumin promoter and enhancer sequences, and the entire human lecithin-cholesterol acyltransferase (LCAT) gene with 550 bp of 3' untranslated region. Plasma LCAT activities in transgenic mice are increased by 2.6- to 10.8-fold over the non-transgenic controls.